These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26419356)

  • 1. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
    Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
    BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Pleasure and Motivation in Schizophrenia: A Randomized Controlled Clinical Trial.
    Favrod J; Nguyen A; Chaix J; Pellet J; Frobert L; Fankhauser C; Ismailaj A; Brana A; Tamic G; Suter C; Rexhaj S; Golay P; Bonsack C
    Psychother Psychosom; 2019; 88(2):84-95. PubMed ID: 30783071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
    Bègue I; Kaiser S; Kirschner M
    Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Positive Emotion Regulation Training on Negative Symptoms and Social Functioning in Schizophrenia: A Field Test.
    Favrod J; Nguyen A; Tronche AM; Blanc O; Dubreucq J; Chereau-Boudet I; Capdevielle D; Llorca PM
    Front Psychiatry; 2019; 10():532. PubMed ID: 31404331
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
    Kirkpatrick B
    J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
    Guessoum SB; Le Strat Y; Dubertret C; Mallet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
    Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
    BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metacognitive training for schizophrenia: a multicentre randomised controlled trial.
    Briki M; Monnin J; Haffen E; Sechter D; Favrod J; Netillard C; Cheraitia E; Marin K; Govyadovskaya S; Tio G; Bonin B; Chauvet-Gelinier JC; Leclerc S; Hodé Y; Vidailhet P; Berna F; Bertschy AZ; Vandel P
    Schizophr Res; 2014 Aug; 157(1-3):99-106. PubMed ID: 24972754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticipatory pleasure skills training: a new intervention to reduce anhedonia in schizophrenia.
    Favrod J; Giuliani F; Ernst F; Bonsack C
    Perspect Psychiatr Care; 2010 Jul; 46(3):171-81. PubMed ID: 20591125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia.
    Nguyen A; Frobert L; McCluskey I; Golay P; Bonsack C; Favrod J
    Front Psychiatry; 2016; 7():13. PubMed ID: 26924992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
    Mach C; Dollfus S
    Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing primary vs secondary negative symptoms and apathy vs expression domains.
    Kirkpatrick B
    J Clin Psychiatry; 2014 Apr; 75(4):e09. PubMed ID: 24813410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [History and current state of the problem of negative disorders (research of nosological period)].
    Smulevich AB; Lobanova VM; Voronova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):122-130. PubMed ID: 33728861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
    Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
    Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor savouring and low self-efficacy are predictors of anhedonia in patients with schizophrenia spectrum disorders.
    Cassar R; Applegate E; Bentall RP
    Psychiatry Res; 2013 Dec; 210(3):830-4. PubMed ID: 24135552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.